Acute graft-versus-host disease does not require alloantigen expression on host epithelium

Nature Medicine

Volumn 8, Issue 6, 2002, Pages 575-581

  Teshima, Takanori ^a   Ordemann, Rainer ^a   Reddy, Pavan ^a   Gagin, Svetlana ^a   Liu, Chen ^b   Cooke, Kenneth R ^a   Ferrara, James L M ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; INTERLEUKIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; EPITHELIUM; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TISSUE INJURY;

ACUTE DISEASE; ANIMALS; ANTIGEN-PRESENTING CELLS; BONE MARROW TRANSPLANTATION; EPITHELIUM; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-1; ISOANTIGENS; MICE; MICE, INBRED C57BL; TRANSPLANTATION CHIMERA; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0036281797     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0602-575     Document Type: Article

References (38)

1. Prevention of graft versus host disease by inactivation of host antigen-presenting cells
2. Graft versus host disease
3. Graft-versus-host disease of the liver
4. The role of cell-mediated cytotoxicity in acute GvHD after MHC matched allogeneic bone marrow transplantation in mice
5. Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease
6. T-cell subsets in graft-vs.-host disease
7. Expression of la antigen on epidermal keratinocytes in graft-versus-host disease
8. Graft-versus-host disease induces expression of la antigen in rat epidermal cells and gut epithelium
9. Induction of la antigen in rat epidermal cells and gut epithelium by immunological stimuli
10. Homeostatic T cell proliferation. How far can T cells be activated to self-ligands?
11. Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection
12. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice
13. Mechanisms of T-cell-mediated cytotoxicity in vivo and in vitro
14. Total body irradiation and acute graft versus host disease. The role of gastrointestinal damage and inflammatory cytokines
15. Differential effects of anti-Fas ligand and anti-tumor necrosis factorα antibodies on acute graft-versus-host disease pathologies
16. Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia
17. + cells in class I different hosts
18. IL-1α, IL-1β, and IFN-γ mark β cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes
19. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor α during graft-versus-host disease
20. Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation
21. +T cells each can utilize a perforin-dependent pathway to mediate lethal graft-versus-host disease in major histo-compatibility complex-disparate recipients
22. Involvement of Fas-mediated apoptosis in the hematopoietic progenitor cells of graft-versus-host reaction-associated myelosuppression
23. Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection
24. Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4(+) donor T cells: Involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesis
25. Effector lymphocytes in autoimmunity
26. A major role for the Fas pathway in acute graft-versus-host disease
27. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-versus-host disease
28. Lymphocyte traffic control by chemokines
29. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease
30. Distinct patterns and kinetics of chemokine production regulate dendritic cell function
31. Graft versus leukemia
32. +T cells in major histocompatibility complex class II-deficient mice
33. Immunodeficiency in graft-versus-host reaction. I. Mechanism of immune suppression
34. Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis
35. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation. I. The roles of minor H antigens and endotoxin
36. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation
37. Interleukin-11 promotes T-cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation
38. Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation